Effect of depression on mortality in implantable cardioverter defibrillator recipients-findings from the prospective LICAD study

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 8, 2011, Pages 991-997

  Tzeis, Stylianos ^a   Kolb, Christof ^a   Baumert, Jens ^a   Reents, Tilko ^a   Zrenner, Bernhard ^a   Deisenhofer, Isabel ^a   Ronel, Joram ^a   Andrikopoulos, George ^b   Ladwig, Karl Heinz ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b HENRY DUNANT HOSPITAL   (Greece)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

depression; implantable cardioverter defibrillator; mortality

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SCREENING TEST; SYMPTOM; THERAPY EFFECT;

ADULT; AGED; CARDIOMYOPATHIES; COHORT STUDIES; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; DEPRESSION; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

EID: 80051677836     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03081.x     Document Type: Article

References (30)

1. Barth J, Schumacher M, Herrmann-Lingen C,. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med 2004; 66: 802-813. (Pubitemid 39552862)
2. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ,. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006; 48: 1527-1537. (Pubitemid 44528168)
3. Jiang W, Kuchibhatla M, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, et al,. Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 2007; 154: 102-108. (Pubitemid 46920483)
4. Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG,. Five year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105: 1049-1053. (Pubitemid 34212612)
5. Vaccarino V, Kasl SV, Abramson J, Krumholz HM,. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001; 38: 199-205. (Pubitemid 32613851)
6. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, Van Den Brink RH, et al,. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosom Med 2004; 66: 814-822. (Pubitemid 39552863)
7. Januzzi JL, Stern TA, Pasternak RC, DeSanctis RW,. The influence of anxiety and depression on outcomes of patients with coronary disease. Arch Intern Med 2000; 160: 1913-1921. (Pubitemid 30437576)
8. Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, Murburg MM, et al,. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1994; 51: 411-422. (Pubitemid 24176819)
9. Carney RM, Blumenthal JA, Freedland KE, Stein PK, Howells WB, Berkman LF, Watkins LL, et al,. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005; 165: 1486-1491. (Pubitemid 41058028)
10. Carney RM, Howells WB, Blumenthal JA, Freedland KE, Stein PK, Berkman LF, Watkins LL, et al,. Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom Med 2007; 69: 4-9. (Pubitemid 46148359)
11. Luukinen H, Laippala P, Huikuri HV,. Depressive symptoms and the risk of sudden cardiac death among the elderly. Eur Heart J 2003; 24: 2021-2026. (Pubitemid 37420449)
12. Carney RM, Freedland KE, Rich MW, Smith LJ, Jaffe AS,. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med 1993; 95: 23-28.
13. Watkins LL, Blumenthal JA, Davidson JR, Babyak MA, McCants CB Jr, Sketch MH Jr,. Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med 2006; 68: 651-656. (Pubitemid 44454631)
14. Ladwig KH, Kieser M, König J, Breithardt G, Borggrefe M,. Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. Eur Heart J 1991; 12: 959-964.
15. Sicouri S, Antzelevitch C,. Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf 2008; 7: 181-194. (Pubitemid 351447701)
16. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ,. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999; 9: 163-168. (Pubitemid 29316079)
17. Whang W, Albert CM, Sears SF Jr, Lampert R, Conti JB, Wang PJ, Singh JP, et al,. TOVA Study Investigators. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: Results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 2005; 45: 1090-1095. (Pubitemid 40432444)
18. Thomas SA, Friedmann E, Kelley FJ,. Living with an implantable cardioverter-defibrillator: A review of the current literature related to psychosocial factors. AACN Clin Issues 2001; 12: 156-163.
19. Musselman DL, Evans DL, Nemeroff CB,. The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch Gen Psychiatry 1998; 55: 580-592. (Pubitemid 28340345)
20. Ladwig KH, Deisenhofer I, Simon H, Schmitt C, Baumert JJ,. Posttraumatic stress symptoms as predictor for mortality in patients with implantable cardioverter-defibrillators (ICD). Results from the prospective "Living with an Implantable Cardioverter Defibrillator (LICAD) Study. Arch Gen Psychiatry 2008; 65: 1324-1330.
21. Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C,. Characteristics associated with low treatment satisfaction in patients with implanted cardioverter defibrillators: Results from the LICAD study. Pacing Clin Electrophysiol 2005; 28: 506-513. (Pubitemid 40847500)
22. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370. (Pubitemid 13098606)
23. Herrmann CH, Buss U, Snaith RP,. Psychologisches Screening von Patienten einer kardiologischen Akutklinik mit einer deutschen Fassung der "Hospital anxiety and depression (HAD) Scala." Psychother Psychosom Med Psychol 1991; 41: 83-92.
24. Olssøn I, Mykletun A, Dahl AA,. The Hospital Anxiety and Depression Rating Scale: A cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005; 5: 46-52.
25. Sears SF Jr, Todaro JF, Lewis TS, Sotile W, Conti JB,. Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review. Clin Cardiol 1999; 22: 481-489. (Pubitemid 29302759)
26. Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adalet K,. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 2006; 29: 619-626. (Pubitemid 43886614)
27. Suzuki T, Shiga T, Kuwahara K, Kobayashi S, Suzuki S, Nishimura K, Suzuki A, et al,. Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: A 2-year longitudinal study. Pacing Clin Electrophysiol 2010; 33: 1455-1461.
28. Francis JL, Weinstein AA, Krantz DS, Haigney MC, Stein PK, Stone PH, Gottdiener JS, et al,. Association between symptoms of depression and anxiety with heart rate variability in patients with implantable cardioverter defibrillators. Psychosom Med 2009; 71: 821-827.
29. Pedersen SS, van Domburg RT, Theuns DAMJ, Jordaens L, Erdman RAM,. Type D personality: A determinant of anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med 2004; 66: 714-719. (Pubitemid 39332358)
30. Johansen JB, Pedersen SS, Spindler H, Andersen K, Nielsen JC, Mortensen PT,. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: A single-centre, cross-sectional study in 610 patients. Europace 2008; 10: 545-551. (Pubitemid 351775296)